Search Results 111-120 of 16862 for Linaclotide

  1. https://www.mayoclinic.org/arabic_procedure_concepts.xml

  2. Hepatobiliary Cancer SPORE Quarterly Newsletter - Mayo Clinic

    Dr. Roberts' laboratory has made major, unique and widely acknowledged contributions to the understanding and treatment of hepatocellular.

  3. Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia - Mayo Clinic

    Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work in ...

  4. Endocrinology - Clinical trials

    [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

  5. A Study to Evaluate Belinostat and Guadecitabine or ASTX727 to Treat Unresectable and Metastatic Conventional Chondrosarcoma - Mayo Clinic

    Belinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as guadecitabine, work in ...

  6. A Study to Evaluate the Long-Term Safety of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD) - Mayo Clinic

    About this study. The purpose of this study is to assess the long-term tolerability and safety of oral nintedanib treatment in patients with Progressive ...

  7. Low-grade UTUC Treated with Nadofaragene Firadenovec Administered to Renal Pelvis - Mayo Clinic

    About this study. The primary purpose of this trial is to evaluate the safety \& tolerability of Nadofaragene Firadenovec in subjects with LG-UTUC.

  8. https://www.mayoclinic.org/spanish_procedure_concepts.xml

  9. NL-201 in Patients With Relapsed or Refractory Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.